Cooper Companies (COO) Cash from Investing Activities (2009 - 2026)
Cooper Companies (COO) recorded quarterly Cash from Investing Activities of -$90.0 million in Q2 2026, up 12.54% quarter-over-quarter from -$102.9 million in Q1 2026, and down 13.64% year-on-year from -$104.2 million in Q2 2025.
Cooper Companies (COO) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$90.0 million for Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 13.64% year-over-year to -$90.0 million; the trailing twelve-month figure through Apr 2026 stood at -$389.8 million (up 28.04% YoY), and the FY2025 full-year result was -$372.9 million, up 51.23% from the prior year.
- Cash from Investing Activities was -$90.0 million for Q2 2026 at Cooper Companies, up from -$102.9 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$15.7 million in Q2 2022 and troughed at -$1.7 billion in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$98.4 million (2025), against an average of -$200.6 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 1130.14% in 2022, then surged 93.21% in 2023.
- Year by year, Cash from Investing Activities stood at -$99.7 million in 2022, then sank by 61.28% to -$160.8 million in 2023, then slumped by 50.25% to -$241.6 million in 2024, then soared by 59.11% to -$98.8 million in 2025, then increased by 8.91% to -$90.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$90.0 million in Q2 2026, -$102.9 million in Q1 2026, and -$98.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -90.00 Mn |
| Apr 30, 2026 | -90.00 Mn |
| Jan 31, 2026 | -102.90 Mn |
| Jan 31, 2026 | -102.90 Mn |
| Oct 31, 2025 | -98.80 Mn |
| Oct 31, 2025 | -98.80 Mn |
| Jul 31, 2025 | -98.10 Mn |
| Jul 31, 2025 | -98.10 Mn |
| Apr 30, 2025 | -79.20 Mn |
| Apr 30, 2025 | -79.20 Mn |
| Jan 31, 2025 | -96.80 Mn |
| Jan 31, 2025 | -96.80 Mn |
| Oct 31, 2024 | -241.60 Mn |
| Oct 31, 2024 | -241.60 Mn |
| Jul 31, 2024 | -124.10 Mn |
| Jul 31, 2024 | -124.10 Mn |
| Apr 30, 2024 | -74.80 Mn |
| Apr 30, 2024 | -74.80 Mn |
| Jan 31, 2024 | -324.10 Mn |
| Jan 31, 2024 | -324.10 Mn |